EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study

Anna Graber-Naidich, Eunji Choi, Julie T Wu, Timothy J Ellis-Caleo, Joel Neal, Heather A Wakelee, Allison W Kurian, Summer S Han

Clinical Lung Cancer · 2024

DOI: 10.1016/j.cllc.2024.08.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2024. Verfasst von Anna Graber-Naidich und 7 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Sciences Unit, Stanford University, Stanford, CA. Hauptthemen laut MEDLINE: Lung Neoplasms, Neoplasms, Second Primary, Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Foundation for the National Institutes of Health, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Long-term breast cancer (BC) survivors are known to develop second malignancies, with second primary lung cancer (SPLC) one common type. Smoking was identified as a main risk factor for SPLC among BC survivors. These findings were limited to the U.S. and focused on smoking status, not incorporating cumulative smoking exposures (eg, pack-years). We examine SPLC incidence and evaluate the associations between SPLC risk and cumulative cigarette smoking exposures and other potential factors among BC survivors in a prospective European cohort. METHODS: Of 502,505 participants enrolled in the UK Biobank in 2006 to 2010, we identified 8429 patients diagnosed with BC between 2006 and 2016 and followed for second malignancies through 2016. Smoking information was collected at enrollment, and treatment data were collected using electronic health records. Multivariable cause-specific Cox regression (CSC) evaluated the association between each factor and SPLC risk. RESULTS: Of 8429 BC patients, 40 (0.47%) developed SPLC over 45,376 person-years. The 10-year cumulative SPLC incidence was 0.48% (95% CI = 0.33%-0.62%). The CSC analysis confirmed the association between SPLC and ever-smoking status (adjusted hazard-ratio (aHR) = 3.46 (P < .001). The analysis showed a 24% increment in SPLC risk per 10 smoking pack-years among BC survivors (aHR = 1.24 per-10 pack-years, P = .01). The associations between SPLC and other variables remained statistically insignificant. We applied the USPSTF lung cancer screening eligibility criteria and found that 80% of the 40 BC survivors who developed SPLC would have been ineligible for lung cancer screening. CONCLUSION: In a large, European cohort, cumulative smoking exposure is significantly associated with SPLC risk among BC survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNeoplasms, Second PrimaryBreast NeoplasmsCancer SurvivorsSmokingBiological Specimen BanksHumansFemaleMiddle AgedUnited KingdomAgedRisk FactorsProspective StudiesIncidenceFollow-Up StudiesAdultCohort StudiesUK Biobank

Stichwörter der Autor:innen

Breast CancerBreast cancerSecond Primary Lung CancerSmoking

Autor:innen und Institutionen

  • Quantitative Sciences Unit, Stanford University, Stanford, CA.
  • Quantitative Sciences Unit, Stanford University, Stanford, CA; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY.
  • Department of Hematology, Stanford University School of Medicine, Stanford, CA.
  • Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA.
  • Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA.
  • Quantitative Sciences Unit, Stanford University, Stanford, CA; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA. Electronic address: summer.han@stanford.edu.

Förderung

  • NCI NIH HHS
  • Foundation for the National Institutes of Health
  • National Institutes of Health

Zitieren

APA

Graber-Naidich, A., Choi, E., Wu, J. T., Ellis-Caleo, T. J., Neal, J., Wakelee, H. A., Kurian, A. W., & Han, S. S. (2024). Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2024.08.017

Vancouver

Graber-Naidich A, Choi E, Wu JT, Ellis-Caleo TJ, Neal J, Wakelee HA, et al. Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study. Clinical Lung Cancer. 2024. doi:10.1016/j.cllc.2024.08.017

BibTeX
@article{GraberNaidich2024,
  author = {Graber-Naidich, Anna and Choi, Eunji and Wu, Julie T and Ellis-Caleo, Timothy J and Neal, Joel and Wakelee, Heather A and Kurian, Allison W and Han, Summer S},
  title = {Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study},
  journal = {Clinical Lung Cancer},
  year = {2024},
  doi = {10.1016/j.cllc.2024.08.017}
}
Kostenlos starten →